The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Baxter International Inc

NYSE: BAX
Last

(U.S.) $63.84

Today's change-0.08 -0.13%
Updated October 18 4:00 PM EDT. Delayed by at least 15 minutes.
 

Baxter International Inc

NYSE: BAX
Last

(U.S.) $63.84

Today's change-0.08 -0.13%
Updated October 18 4:00 PM EDT. Delayed by at least 15 minutes.

Baxter International Inc down (U.S.)$0.08

Baxter International Inc closed lower Wednesday, dropping (U.S.)$0.08 or 0.13% to (U.S.)$63.84. Over the last five days, shares have gained 2.95% and are currently 1.41% off of the 52-week high. Shares have outperformed the S&P 500 by 13.13% during the last year.

Key company metrics

  • Open(U.S.) $63.90
  • Previous close(U.S.) $63.92
  • High(U.S.) $64.11
  • Low(U.S.) $63.54
  • Bid / Ask-- / --
  • YTD % change+43.98%
  • Volume1,340,081
  • Average volume (10-day)2,200,100
  • Average volume (1-month)2,073,979
  • Average volume (3-month)2,409,820
  • 52-week range(U.S.) $43.13 to (U.S.) $64.75
  • Beta0.70
  • Trailing P/E38.94×
  • P/E 1 year forward26.74×
  • Forward PEG2.01×
  • Indicated annual dividend(U.S.) $0.64
  • Dividend yield1.00%
  • Trailing EPS(U.S.) $1.64
Updated October 18 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.22%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue2,6052,4752,6452,558
Total other revenue--------
Total revenue2,6052,4752,6452,558
Gross profit1,1411,0581,1391,107
Total cost of revenue1,4641,4171,5061,451
Total operating expense2,2992,1312,3632,420
Selling / general / administrative603560619611
Research & development157126152129
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)752886229
Other operating expenses, total--------
Operating income306344282138
Interest income (expense), net non-operating-21-20-20-20
Gain (loss) on sale of assets--------
Other--------
Income before tax306328279128
Income after tax264273240127
Income tax, total4255391
Net income265272243130
Total adjustments to net income--------
Net income before extra. items264273240127
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items264273240127
Inc. avail. to common incl. extra. items265272243130
Diluted net income265272243130
Dilution adjustment--------
Diluted weighted average shares555551548551
Diluted EPS excluding extraordinary itemsvalue per share0.480.500.440.23
Dividends per sharevalue per share0.160.130.130.13
Diluted normalized EPSvalue per share0.560.520.570.49